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Abstract.  We have used autoantibodies to probe the 
function of three human centromere proteins in mito- 
sis.  These antibodies recognize three human polypep- 
tides in immunoblots:  CENP-A (17 kD),  CENP-B (80 
kD),  and CENP-C  (140 kD).  Purified anticentromere 
antibodies (ACA-IgG) disrupt mitosis when introduced 
into tissue culture cells during interphase.  We have 
identified two execution points for antibody inhibition. 
Antibodies injected into the nucleus >/3  h before mi- 
tosis prevent the chromosomes from undergoing nor- 
mal prometaphase movements in the subsequent mito- 
sis.  Antibodies injected in the nucleus during late G~ 
cause cells to arrest in metaphase.  Surprisingly, anti- 
bodies introduced subsequent to the beginning of 
prophase do not block mitosis.  These results  suggest 
that the CENP antigens  are involved in two essential 
interphase events that are required for centromere ac- 
tion in mitosis. These may include centromere assembly 
coordinate with the replication of o~-satellite  DNA at 
the end of S phase and the structural maturation of the 
kinetochore that begins at prophase. 
T  IaE dramatic movements that chromosomes undergo 
during mitosis have held the interest of cell biologists 
for over a century, and yet the underlying mechanisms 
remain unsolved (19, 52).  These movements begin at pro- 
metaphase, when the nuclear envelope first breaks down and 
chromosomes come into  contact with  microtubules.  The 
progressive attachment of microtubules to first one sister 
centromere, then the other during prometaphase results in a 
balanced production of force that eventually poises the chro- 
mosome midway between the  spindle poles.  Anaphase  is 
initiated after all of the chromosomes have moved to the mid- 
zone forming a metaphase plate. During anaphase the dis- 
joined sister chromatids move in concert towards the spindle 
poles.  The locations and identity of the mechanochemical 
motors involved in these movements are currently the subject 
of intense investigation. 
One of the most dramatic aspects of mitotic movements is 
the extent to which they are held under strict regulatory con- 
trol.  Each  mitosis  involves a  crucial  "decision" point,  at 
which the metaphase cell abruptly disjoins the sister chro- 
matids and initiates their concerted movement towards the 
spindle poles. If this process is initiated before all chromo- 
somes are aligned at the midplane of the mitotic spindle the 
progeny will be aneuploid. This checkpoint is one of a num- 
ber of points where feedback networks regulate the progress 
of the cell cycle (16).  Cultured cells in metaphase will wait 
for extended periods for a single monooriented chromosome 
to achieve its  proper position on the metaphase plate (35, 
53). 
The kinetochore appears to be a key player in mitotic chro- 
mosome movements. Observations of kinetochore microtu- 
bules during anaphase have indicated that they themselves do 
not move, but rather are consumed by the chromosomes dur- 
ing anaphase A movement (13, 14).  Two observations sug- 
gest that the mechanochemical motor responsible for chro- 
mosome movements along microtubules is located close to 
the kinetochore. First, kinetochores detached from prema- 
turely condensed chromosomes can undergo mitotic move- 
ments (4). Second, chromosomes can move to within 1 #m 
of the amputated edge of a cut spindle (28). 
The kinetochore develops into a disk-shaped structure at 
the surface of the centromere during early mitosis. It is com- 
posed of four layers (for reviews see [5, 31, 34]); an outer- 
most fibrous corona, an outer dense disk (in which microtu- 
bules normally terminate), an unstained zone, and an inner 
disk that is embedded in the surface of the centromeric chro- 
matin.  The structure  is pleiomorphic.  The corona is  not 
readily  seen  when  there  are  microtubules  bound  to  the 
kinetochore, and the inner plate is not seen when cells are 
arrested in prometaphase with colcemid (37). A recent study 
suggests that the mechanochemical motor responsible for the 
earliest poleward movements observed during prometaphase 
may be located in the fibrous corona (36). 
Clearly, the identification of kinetochore proteins is a ma- 
jor priority, and yet little is known about kinetochore compo- 
sition.  The  only  polypeptide that  has  been  convincingly 
mapped  to  this  region  is  tubulin,  which  is  found  in  the 
fibrous corona in colcemid-arrested cells (26). Beyond this, 
the protein composition of the kinetochore is controversial. 
A major breakthrough in our understanding of this region 
© The Rockefeller  University  Press, 0021-9525/90/10/1519/15  $2.00 
The Journal of Cell Biology, Volume  111, October  1990 1519-1533  1519 came about in  1980 when it was  shown that sera from pa- 
tients with the CREST variant of progressive systemic scle- 
rosis often contain autoantibodies that bind to the centro- 
mere  regions  of  mitotic  chromosomes  (27).  These  are 
referred to as anticentromere antibodies (ACAs) ~.  We and 
others  have  used  a  combination  of immunoblotting  and 
affinity purification experiments to identify three structur- 
ally related target antigens in human cells that are recognized 
by these autoantibodies (7, 15, 47). We designated these the 
centromere  protein  (CENP)  antigens,  CENP-A  (17-kD), 
CENP-B (80 kD), and CENP-C (140 kD) (7). A subsequent 
study indicated that a 50-kD antigen first recognized in ro- 
dent cells  (7) could also be detected in human cells,  and 
designated this antigen CENP-D (21). 
CENP-B is the best characterized of these proteins. It has 
been  cloned and  sequenced,  and  specific polyclonal and 
monoclonal antibodies have been raised to bacterial fusion 
proteins (10).  We have used these antibodies together with 
a newly developed series of ultra-small colloidal gold probes 
to examine the distribution of CENP-B within the centro- 
mere by  immunoelectron microscopy (6).  We  found that 
CENP-B is broadly distributed throughout the centromeric 
heterochromatin beneath  the  kinetochore,  and  is  not ob- 
served in the kinetochore itself (6). This is consistent with 
our detection of CENP-B at the inactive centromere of a sta- 
ble dicentric chromosome (11) (such inactive centromeres 
are thought to lack kinetochores [48]). The immunolocali- 
zation results are also consistent with the recent demonstra- 
tion that CENP-B binds to a specific 17-bp sequence present 
in some a-satellite DNA monomers (23). a-satellite DNA is 
a family of highly repetitive DNA sequences that comprises 
"~5 % of the human genome and is localized exclusively at 
the centromeres (41).  Both CENP-B and a-satellite DNA 
have been shown to vary in amount from chromosome to 
chromosome, strengthening the argument that these two cen- 
tromere elements are associated with each other in vivo. To- 
gether, these studies suggest that the majority of the CENP-B 
protein  is  distributed  throughout the  centromeric hetero- 
chromatin, with little or none at the kinetochore itself. These 
results are less consistent with the suggestion that CENP-B 
binds directly to microtubules, which was proposed based on 
a crosslinking study showing that an 80-kD Chinese hamster 
protein can be crosslinked to exogenous tubulin in vitro (1). 
The other three CENP antigens are less well characterized. 
CENP-C  may be closely associated with the kinetochore, 
since this antigen is found only at the active centromere of 
stable  dicentric chromosomes  (11). Affinity-purified anti- 
CENP-C antibodies stain the centromere region of all chro- 
mosomes uniformly, suggesting that this antigen may be as- 
sociated with an invariant structure such as the kinetochore 
(7, 11). Little is known about the properties of the CENP-C 
polypeptide, except that it, like CENP-B, is a component of 
the  mitotic  chromosome scaffold  (8).  Nothing  is  known 
about the distribution of CENP-A or CENP-D in chromo- 
somes.  All antibodies affinity purified from CENP-A and 
CENP-D  that  we  have obtained  to  date  cross-react with 
CENP-B (17). Biochemically, CENP-A behaves in many ways 
like a histone, and it cofractionates with nucleosomes (30). 
The recent purification of CENP-A should lead to major ad- 
1. Abbreviations used in this paper: ACA, anticentromere antibody; CENP, 
centromere protein. 
vances in our understanding of this antigen (D. Palmer and 
R.  Margolis, personal communication). 
The ultrastructural distribution of CENP-C and/or CENP- 
A within the centromere has been deduced by comparison 
of the staining obtained with monospecific anti-CENP-B an- 
tibodies to that obtained with an autoimmune serum that 
recognizes all three CENP antigens. The only difference be- 
tween the two patterns is found in the chromatin lateral to 
the kinetochore plates. This region contains only 5 % of the 
gold grains when anti-CENP-B is used, but contains  18 % 
of the grains when the autoantibody is employed (6). This 
suggests that CENP-C and/or CENP-A are concentrated in 
a ring of chromatin that closely encircles the kinetochore, 
while the kinetochore structure itself rests on a foundation 
of heterochromatin rich in CENP-B. 
The purpose of  the present study was to begin to determine 
whether the CENP antigens perform essential mitotic func- 
tions in vivo. We have purified IgG from sera of patients with 
anticentromere antibodies (ACA-IgG) and injected these into 
cultured cells.  We find that ACA-IgG strongly disrupt the 
course of mitotic events, thus, demonstrating that the CENP 
antigens are essential for mitosis. Surprisingly, for the anti- 
bodies to inhibit mitosis, they must contact their target anti- 
gens  during  the  preceding  interphase.  Furthermore,  two 
different phenotypes are observed after antibody injection. 
These depend on the time in the cell cycle at which injection 
takes place. We are able to define two execution points for 
antibody disruption of centromere function at mitosis. We 
use this terminology by analogy to its usage in cell cycle 
analysis  (32),  to refer to that point in the cell cycle after 
which a given mitotic process is no longer sensitive to inhibi- 
tion by antibody. 
Our results begin to provide some clues as to the role of 
the CENP antigens in the structure/function of the centro- 
mere. We suggest that these antigens are required for pro- 
metaphase chromosome movements and for the timely initi- 
ation of anaphase. 
Materials and Methods 
Cell Culture 
HeLa cells were grown in RPMI (Gibco Laboratories, Grand Island, NY) 
with 5%  calf serum (Hyclone Laboratories,  Logan, UT).  LLC-PK cells 
were grown in DMEM (Gibco Laboratories) with  10%  FBS.  For scrape 
loading experiments, HeLa cells were grown on 35-mm petri dishes. For 
microinjection experiments, cells were grown on photoetched glass cover 
slips (Bellco Glass, Inc.,  Vineland, NJ). 
Scrape Loading 
HeLa cells were scrape loaded by the method of McNeil et al. (25). Cells 
were trypsinized from culture flasks and replated onto 35-mm petri dishes 
at nearly confluent density. 4-8 h after replating, cells were scraped from 
the dish in the presence of 50 #1 serum or purified IgG. Cells were washed 
once in cold serum-free medium and replated onto coverslips in complete 
medium. Cells were fixed and processed for microscopy from 4  h to 5 d 
after replating. 
Loaded cells were identified directly by staining with labeled secondary 
antibody. 20-40 % of cells were found to retain levels of antibody detectable 
by immunofluorescence. The loaded antibody was found not only in the 
cytoplasm, but bound to the centromeres as well. Cells were also processed 
in parallel with antitubulin antibody and DAPI to simultaneously examine 
microtubule and chromosome morphology. 
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Figure 1.  Anticentromere antibodies block mitosis. (A) HeLa cells 
on  indexed coverslips were  grown  into  microcolonies of 20-60 
cells. At time 0  all cells in a  colony were injected with ACA IgG 
(o) or with control IgG (Lx), and the number of cells in the colony 
was noted. The number of  cells in each microcolony was then moni- 
tored periodically for the next 48 h. (B) Flow cytometry profile of 
a population of HeLa cells 17 h after scrape loading with ACA IgG. 
Note  that  in  such  experiments,  only  20-40%  of the  cells  were 
loaded with antibody.  (C)  Flow cytometry profile of HeLa cells 
17 h  after loading with normal human IgG. 
Microinjection 
Either HeLa or LLC-PK cells were plated onto photo-etched coverslips 
(Bellco Glass, Inc.) at a low density and grown for at least 2 d. Clearly iso- 
lated patches of 10-30 cells were identified and all the cells within one patch 
were injected using a Leitz micromanipulator. A video print of each patch 
of injected cells was taken for reidentification of cells later.  Microinjection 
was carried out at 37°C with 20 mM HEPES added to the medium. Cells 
were then fed fresh medium and returned to the incubator. 
Observation of  Injected Cells 
Ceils  were  observed  from  1-48  h  after  injection.  Injected cells  were 
identified by their position on locator grids and examined hourly by phase- 
contrast microscopy. Cells were noted as they entered mitosis and observa- 
tion was continued as they proceeded through mitosis. At different times af- 
ter injection, cells were fixed and stained as described below. 
We determined by flow cytometry (FACS) analysis that the lengths of the 
cell cycle phases for HeLa cells growing under these conditions were: Gh 
13 h; S, 4 h; and G2, 3 h. Injection of either control or anticentromere IgG 
into the cells did not appear to significantly affect their progress through 
the interphase portion of the cell cycle, as judged by the frequency with 
which members of injected colonies were observed to enter mitosis. 
Immunofluorescence 
Cells on glass coverslips were fixed with 3.5% formaldehyde in PBS-azide 
(10 mM NaPO4, pH 7.4,  0.15 M NaCI,  1 mM EGTA, 0.01% NAN3) for 5 
min at room temperature. Cells were washed three times for 3 min each at 
room temperature in lysis/wash buffer (150 mM NaCI,  10 mM Tris pH 7.7, 
0.1%  Triton X-100,  0.1% BSA). Biotinylated antihuman antibody (Vector 
Laboratories, Burlingame, CA) at  1:1,000 and mouse anti-~ tubulin anti- 
body (Amersham Corp., Arlington Heights, ILl or mouse anti-~ tubulin 
(Accurate Chemical & Scientific Corp., Westbury, NY) at 1:50 was applied 
for 30 min at 37°C. Cells were again washed three times more in buffer fol- 
lowed by incubation in streptavidin: Texas red (Bethesda Research Labs, 
Grand  Island,  NY)  at  1:800  and  fluoresceinated  antimouse  antibody 
(DAKO) at 1:50. Cells were washed three times with buffer. DAPI at 1/zg/ml 
was added in the second wash (51).  Coverslips were mounted onto glass 
slides in Mowiol prepared with PBS (29).  Slides were examined on an 
Olympus Vanox microscope using either a  100x  S plan alx)chromat lens 
with an NA of 1.4, or (when optical sectioning was desired) a 100x achro- 
mat, NA 1.3. In some cases, images were photographed directly on Kodak 
T-max 400 film, or Microfluor Hypertech film. Typically,  images were ob- 
tained with a DAGE SIT camera driven by a Perceptics Hyperscope image 
processing program. These images were subjected to a Fourier sharpening 
algorithm and photographed directly from the monitor on Kodak T-max 400 
film. 
Antibody Purification 
All sera came from the collection of the Division of Rheumatic Diseases, 
Farmington, CT. The following sera were used: ACA(+) that inhibited mi- 
tosis either as serum or IgG-J-1311,  A-1219,  KG, SN, GS, AP, F-2248, 
J-3051,  H-345, G-2016,  J-31;  ACA(+) that failed to inhibit mitosis either 
as  serum or  lgG-G-1942,  BM,  E-186,  H-2870;  antitopo I  (+)-NM, 
K-2432,  1(-782,  K-724;  antitopo II  (+)-K-1618;  other ACA(-) patient 
control-K-1137; normal sera-WE, SE, TA. 
Antibodies were purified from whole human serum using Protein A 
sepharose columns as  suggested by  the  manufacturer  (Repligen,  Cam- 
bridge, MA). 1 ml of Protein A sepharose per ml of whole serum was used. 
Serum was run over the column and washed with 5 mM KPO4, pH 8. Anti- 
bodies were eluted from the column with 0.2 M glycine:HCl, pH 2.5, at 
room temperature. Alternatively, small volumes of serum were batch in- 
cubated and eluted. Pooled fractions containing antibody were concentrated 
and dialyzed into PBS using Centricon concentrators (Amicon Corp., Dan- 
vers, MA) to "~5 mg/ml. 
Preparation of  LLC-PK and HeLa Nuclei 
and Chromosomes 
LLC-PK cells were grown in T-150 tissue culture flasks (Bellco Glass, Inc.) 
and nuclei were prepared as described (38).  HeLa nuclei were prepared 
from cells grown in spinner culture.  Approximately 1  x  10  s Hela ceils 
were used per nuclei preparation. Cells were centrifuged at 900 g for 3 min 
and resuspended in 50 mi RSB (10 mM Tris:HC1,  pH 7.4,  10 mM NaC1, 
5 mM MgCI2) plus 10 KIU/ml trasylol (aprotinin; Mobay Chemical Corp., 
Pittsburgh, PAl and 0.1 mM PMSF at room temperature. Cells were swollen 
for 5 min and centrifuged as above and the supernatant was removed by aspi- 
ration.  10 ml of ice cold lysis buffer (15 mM Tris-HC1,  pH 7.4,  0.3 mM 
spermine, 0.75 mM spermidine, 2 mM K-EDTA, pH 7.4, 80 mM KC1, 0.1% 
digitonin, plus trasylol and PMSF) were added to the cells and transferred 
to a  15-ml glass dounce homogenizer. Cells were homogenized on ice and 
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Figure 2.  Percentage of mitotic-injected cells reaching metaphase 
as a function of the time of injection. The upper panel summarizes 
the data  for cytoplasmic (o)  and nuclear  (I)  injections of ACA- 
IgG.  Mitotic cells that did not reach metaphase were arrested in 
pseudo-prometaphase.  Note that it takes  "~8 h  for antibodies in- 
jected into the cytoplasm to produce an affect comparable to nu- 
clear injections. This corresponds well with the rate of movement 
of ACA-IgG into the nucleus determined as described in the text. 
The lower two panels present the data used to calculate the percent- 
age figures. The total injected cells observed to enter mitosis at the 
indicated time after injection are shown by the open bars.  Those 
injected cells that were observed to progress to metaphase are indi- 
cated by the solid bars. 
Bernat et a]. Inhibition of Mitosis by Anticentromere Antibodies  1521 Figure 3. HeLa cells arrested in pseudo-prometaphase at time of fixation. All cells were injected in the nucleus. A, C, and E show a DAPI 
stain for DNA. B, D, and F show indirect immunofluorescence staining for tubulin. The cells shown in the various panels had been in 
mitosis for the following times before fixation: (A and B)  1.5 h; (C-F) 2 h. Bar, (F)  1 #m. 
transferred to a 50-ml round bottom centrifuge tube (Sorvall Instruments 
Div., Newton, CT). Buffer 3 (5 mM Tris:HCl, pH 7.4, 2 mM KCI, 2 mM 
K-EDTA, pH 7.4, 0.375 mM spermidine, 0.1% digitonin, plus trasylol and 
PMSF) was added to a total volume of 50 ml and the nuclei were centrifuged 
for 10 min at 1,000 g. Nuclei were washed once with the same buffer and 
centrifuged for 10 min at  1,000 g. Purified nuclei were resuspended in  1 
ml buffer 4  (5 mM Tris:HCl, pH 7.4, 2 mM KCI, 0.375 Spermidine, plus 
trasylol).  After addition of Ca  2÷  to  2  mM,  DNA was digested with 40 
/xg/ml micrococcal nuclease (Worthington Biochemical Corp.,  Freehold, 
NJ)  for 30 min on ice.  Nuclei were aliquoted and frozen at  -70°C. 
HeLa ceils growing in RPMI 1640 plus 5 % calf serum (Hyclone Labora- 
tories) were blocked in mitosis with 100 ng per ml colcemid for 20 h. Cells 
were harvested as described above, and crude chromosomes were prepared 
as described above for interphase nuclei except that centrifugation was for 
3,000 g  for 20 min in all steps subsequent to cell lysis. 
Electrophoresis and immunoblotting were performed as previously de- 
scribed (8). 
Results 
IgG purified from the sera of patients with anticentromere 
antibodies (ACA-IgG) were introduced into cells by either of 
two methods.  Direct needle microinjection was used when 
we wished to monitor the effects of the antibody on the prog- 
ress of individual ceils through mitosis.  ACA-IgG were in- 
jected into either LLC-PK (pig kidney epithelial)  or HeLa 
cells.  LLC-PK cells were used for some experiments since 
they remain flattened  during mitosis, enabling chromosome 
movement to be observed more clearly in vivo. Immunoblot- 
ting of LLC-PK nuclei confirmed that these cells express an- 
tigens that comigrate with CENP-C and CENP-B (see  Fig. 
10). 
Certain  experiments  utilized the  scrape loading method 
for  the  simultaneous  introduction  of antibodies  into  the 
cytoplasm of a large number of cells (25).  This enabled us 
to examine the effect of the antibody on populations of cells 
over longer periods of time. 
Microinjection  of  ACA-IgG Disrupts Mitosis 
Cells were plated sparsely on locator coverslips and allowed 
to grow into microcolonies of 10-30 individuals.  All cells 
in a colony were injected with either control IgG or ACA-IgG 
and the cell number was monitored over a period of several 
days. In colonies of HeLa or LLC-PK cells injected with an- 
ticentromere antibodies,  cell  number began to decrease as 
cells attempted to go through mitosis (Fig.  1 A). Most of the 
surviving cells appeared micronucleated when examined by 
phase microscopy and few of them continued to grow nor- 
mally.  Ceils  injected  with  control antibodies  continued to 
grow normally. 
The disruption  of mitotic  events  by ACA-IgG was  con- 
firmed at a  population level  by fluorescence activated cell 
sorting analysis of scrape-loaded cultures. Fig.  1 shows such 
an analysis of two cultures 17 h after loading with antibody. 
In this experiment,  18 % of the cells in the ACA-IgG-loaded 
culture  had  a  G2/M  DNA content  (Fig.  1 B).  This  com- 
pares with  ll%  in the culture loaded with control antibody 
The Journal of Cell Biology,  Volume 111,  1990  1522 Figure 4. Injected LLC-PK cell observed in vivo during mitosis. The panels show the following stages of mitosis (with the time in minutes 
indicated at the lower right of each): (A) metaphase; (B) metaphase with chromosomes falling offthe plate; (C) anaphase; (D) cytokinesis; 
(E) divided  micronucleated  daughter  cells;  (F) same cells after fixation.  Note the chromosomes  trapped  in the cleavage furrow in D. 
Micronuclei are visible in E, and more clearly after fixation in F. Note second ACA-IgG-injected cell undergoing tripolar anaphase (F, top). 
(Fig.  1 C).  This difference is significant,  since in a typical 
loading experiment, only 20-40 % of cells retain levels of an- 
tibody detectable by immunofluorescence. The cessation of 
colony growth and shift towards a G2 DNA content are both 
consistent with the inactivation of centromere function by the 
injected antibody, leading to a disruption of mitotic events. 
Antibody Injection into Mitotic Cells Does Not 
Disrupt Mitosis 
It might be expected that anticentromere antibodies would 
disrupt mitosis by directly interfering  with the  interaction 
between chromosomes and microtubules. To test this possi- 
bility, purified antibodies were injected into LLC-PK cells 
during mitosis and subsequent mitotic events were observed 
by phase-contrast microscopy. Surprisingly,  antibodies  in- 
jected into cells during any stage of mitosis, from prophase 
through telophase,  had no effect on that mitosis other than 
a  slight prolongation of the process.  To determine whether 
this was simply a matter of competition between antibodies 
and microtubules for binding sites on the chromosome, cells 
cultured  in  the  presence of 40  ng/ml nocodazole were in- 
jected with antibody as they entered prophase.  Under these 
conditions preexisting microtubules depolymerize and new 
ones do not assemble.  These injected cells were then held 
for 2 h  in prometaphase in the presence of antibody.  Upon 
removal of the drug,  the injected cells proceeded normally 
through mitosis, even after being exposed to the antibodies 
for several hours. We conclude that the antibody must bind 
to its target antigen at some point before mitosis in order to 
exert its inhibitory effect in these cells. 
Antibody Injection into Interphase Cells 
Disrupts Mitosis 
It proved to be necessary to inject the antibodies into cells 
during interphase in order to observe an inhibitory effect on 
the subsequent mitosis. The microinjection protocol provided 
a  convenient way to determine whether the effects of anti- 
body injection were dependent on the specific cell cycle phase 
Bernat et al. Inhibition of Mitosis by Anticentromere  Antibodies  1523 Figure 5. Cells undergoing various stages of degeneration  of the metaphase configuration during the course of mitotic arrest.  All of these 
cells had visibly attained  metaphase at some time during mitosis as observed by phase microscopy before fixation. A-F show HeLa cells 
stained  as follows:  (A, C, and E) DAPI stain for DNA; and (B, D, and F) indirect  immunofluorescence  staining  for tubulin.  The cells 
shown in the various  panels  had been in mitosis for the following times before fixation:  (A and B, left) 5 h; (A and B, right) 4 h; (C and 
D) 4 h; (E and F) 6 h. G and H show an LLC-PK cell that has initiated  anaphase  separation  of sister chromatids  (arrowheads). This cell 
had not been followed in vivo before  fixation.  Bars:  (B)  1 /zm (applies  to A, B, and E-H); (D)  1 #m (applies  to C and D). 
of the recipient cell. Colonies were monitored once an hour 
for cells entering mitosis, beginning as soon as injection was 
completed. Those that entered mitosis within 3 h of injection 
are inferred to have been injected in G2.  Cells that entered 
mitosis >3 h after injection were probably injected in either 
S  or G~.  (Although quantitative  data  on the  length  of the 
cell cycle phases could not be obtained in injected cells, we 
do not believe that the injections exert a significant effect on 
the passage of these cells through interphase;  see Materials 
and Methods.) A  video print was taken of each colony just 
subsequent to injection so that it was possible to keep a de- 
tailed history for every member of the microcolony. Stages 
of mitosis observed for each cell were noted for as long as 
it remained in mitosis (until it either divided or was fixed and 
processed for immunofluorescence). 
Cells  injected  with  ACA-IgG during  interphase  showed 
dramatic defects as they attempted to traverse the subsequent 
mitosis. A complicated pattern of mitotic disruption was ob- 
served with a  range of abnormalities  that depended on the 
site of injection (nucleus or cytoplasm) and cell cycle phase 
of the injected cell. 
Identification of an Execution Point Required for the 
Successful Completion of  Prometaphase 
Chromosome Movements 
If ACA-IgG was  injected  into  the  nucleus  three  or  more 
hours before mitosis, the recipient cells did not successfully 
complete prometaphase chromosome congression and were 
unable  to  form  a  mature  spindle  with  the  chromosomes 
aligned on a metaphase plate.  Cells injected after this time 
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centromeres  in vivo. A and C show in- 
direct  immunofluorescence staining for 
tubulin. (B and D) show the detection of 
the injected ACA-IgG bound to centro- 
meres of chromosomes surrounding the 
spindle with rhodamine-conjugated anti- 
human antibody. ACA were introduced 
into these cells by scrape loading,  and 
the cells were examined 18 h later after 
staining with antihuman antibody to de- 
tect the loaded antibodies.  DAPI stain- 
ing of the DNA (not shown) indicated 
that the ACA staining was limited to the 
centromere regions of the chromosomes, 
which  were  apparently  not  associated 
with the mitotic  spindle.  Staining with 
antitubulin was as described in Materials 
and Methods.  Bar, (C) 1 /zm. 
successfuly completed prometaphase, but arrested at a later 
stage of mitosis (Fig. 2). Flow cytometric analysis indicated 
that the length of G2 in these cells is  '~3 h.  These results 
lead us to conclude that there is an execution point for anti- 
body inhibition at or near the S-G2 boundary. 
Cells receiving intranuclear injections of ACA-IgG >t3 h 
before mitosis remain arrested in mitosis for 2-8 h in a novel 
state that we will refer to as pseudo-prometaphase. (Normal 
mitosis lasts  ~<1  h  in  these cells.)  Pseudo-prometaphase 
cells typically have a  single clump of condensed  chromo- 
somes that apparently do not move from their original loca- 
tions following nuclear envelope breakdown (Fig. 3). In cells 
observed after fixation within  1-2  h  of entry  into  mitosis 
there is often a thin bipolar spindle on one side of the cell, 
beside the cluster of condensed chromosomes. Often these 
spindles are bent in a banana shape with the outer curve pro- 
truding toward the chromosomes. In such instances, micro- 
tubules are observed to emanate from the spindle  into the 
cluster of chromosomes. The bent appearance may arise from 
microtubules that are attached to chromosomes and pull the 
spindle in that direction.  From these observations it appears 
that chromosomes are able to attach to microtubules, but are 
unable to move once attached. We also occasionally observe 
spindles  that  appear to  point  away  from the  chromosome 
mass (Fig. 3, C and D). Spindles in arrested cells are not as 
robust as normal HeLa spindles, which are short and nearly 
round at metaphase. 
An identical pseudo-prometaphase arrest phenotype was 
observed for cells injected in the cytoplasm 14-20 h before 
mitosis. This apparent shift in execution point observed for 
the cytoplasmic injections may reflect a delay in transport of 
the ACA-IgG into the nucleus. Alternatively, ACA-IgG might 
remain in the cytoplasm and disrupt mitosis by a different 
mechanism. To distinguish between these two explanations, 
we conducted the following scrape-loading experiment to ex- 
amine whether antibodies introduced into the cytoplasm en- 
ter the  nucleus  during  interphase  before nuclear  envelope 
breakdown. 
Mitotic  cells  were  obtained  from  nocodazole-synchro- 
nized cultures by selective detachment and replated onto petri 
dishes. After cells had reattached (3 h after shake off), they 
were scrape loaded with ACA and replated in the presence 
ofcolcemid. With colcemid present, any ceils that enter mi- 
tosis would be blocked there, and any cells still in interphase 
must not yet have reentered mitosis. The fate of the loaded 
antibody was tracked by staining cells with anti-human IgG 
at various times after replating. The antibody began to be de- 
tectable on centromeres within the nucleus of cells 4 h after 
loading, and was readily visible in most cells after 8 h.  At 
this point, none of the cells had yet entered mitosis. Thus, 
ACA-IgG enter the nucleus before nuclear envelope break- 
down at mitosis. 
Idenn'fication of an Execution Point 
Required for timely Completion of the 
Metaphase-Anaphase  Transition 
Cells  receiving  nuclear  injections  of ACA-IgG during  G2 
(1-2 h before mitosis) successfully complete prometaphase, 
but remain blocked in  metaphase for a  number of hours. 
These experiments thus reveal the existence of a second exe- 
Bernat et al.  Inhibition  of Mitosis by Anticentroraere  Antibodies  1525 Figure 7. Pseudo-prometaphase-arrested  cells undergoing spindle degeneration.  Examination of the sister chromatids (where they can be 
resolved) suggests that these cells have entered anaphase. A, C, E, and G show DAPI stain for DNA. B, D, F, and H show indirect im- 
munofluorescence staining for tubulin. The cells shown in the various panels had been in mitosis for the following times before fixation: 
(A and B) 5 h; (C and D) 3 h; (E and F) 3.5 h; (G and H) 5 h. Separated chromatids are clearly visible in both A and G (arrowheads). 
Bars:  (B)  1 /xm (applies to A, B, and E-H); (D)  1 #m (applies to C and D). 
cution point for antibody inhibition just before mitosis. This 
execution point appears to affect events required for the tran- 
sition from metaphase to anaphase. 
These metaphase-arrested cells were unusual,  in that the 
metaphase plate appeared to undergo a progressive degener- 
ation over time.  This was most obvious while monitoring 
LLC-PK cells in  vivo as they remained arrested at meta- 
phase. Chromosomes that had been at the plate were observed 
to detach and drift into the peripheral cytoplasm (Fig. 4, A 
and B).  Examination of HeLa cells that had been arrested 
in metaphase for varying lengths of time confirmed the ob- 
servations of living cells. The spindle often appeared normal 
in cells fixed and stained soon after the achievement of meta- 
phase, although in some instances a few detached chromo- 
somes could be seen  (Fig.  5,  A  and B).  Cells  fixed after 
longer intervals  spent at metaphase often had increasingly 
disorganized spindles and chromosomes distributed through- 
out the cytoplasm. Tripolar and quadripolar spindles were 
also observed (Fig.  5,  E  and F).  The stability of the chro- 
mosomal attachment to  the  spindle  appeared to  correlate 
with the cell cycle time of injection.  Cells injected at later 
points in the cycle exhibit a more stable metaphase confor- 
mation. 
This dissolution of the metaphase plate is paradoxical. If 
chromosomes are once able to attach to microtubules and 
undergo prometaphase movements, why do they fall off and 
The Journal  of Cell Biology,  Volume 111, 1990  1526 Figure 8. Cells undergoing abnormal cytokinesis after pseudo-prometaphase block in mitosis. A, C, E, and G show DAPI stain for DNA. 
B, D, F, and H show indirect immunofluorescence staining for tubulin. The cells shown in the various panels had been in mitosis for the 
following times before division: (A and B) 6 h; (C and D) 4 h; (E and F)  1 h; (G and H) 3 h. In every instance these cells have DNA 
trapped in the midbody. In most cases the midbody structures are clearly aberrant. Note the presence of two midbodies side by side in 
E  Bars: (B)  1 #m (applies to A-F); (H)  1 /zm (applies to G and H). 
remain detached from the spindle during metaphase arrest? 
While the detachment might result from kinetochore break- 
age, this seems unlikely, since the injected antibody can be 
visualized directly on the detached chromosomes and not on 
the microtubules (Fig.  6). Alternatively, the antibody might 
interact with centromeres after they detach from the spindle, 
preventing them from reattaching. 
To  test  this  idea,  we  examined  whether  metaphase- 
arrested cells could reestablish a metaphase plate in the pres- 
ence  of  injected  antibody  after  a  brief  exposure  to  the 
microtubule depolymerizing drug, nocodazole. Microcolo- 
nies of HeLa cells were injected with ACA-IgG  under condi- 
tions giving a metaphase arrest and periodically monitored 
for the  appearance  of mitotic  cells.  After cells  had  been 
blocked in metaphase for 2-5 h,  nocodazole (40 nM) was 
added to the dish.  Metaphase plates were no longer visible 
after 1 h in the drug, and the chromosomes appeared to be 
dispersed. At this point cells were released from nocodazole 
and allowed to proceed through mitosis. 
Most uninjected cells completed mitosis within 1 h of re- 
lease from the drug. After another 2 h, cells were fixed and 
stained with DAPI to visualize the chromosomes. All stages 
of mitosis were seen in uninjected mitotic cells.  One-third 
(7/21)  of the  ACA-IgG-injected cells  were  able  to  reform 
Bernat et al. Inhibition  of Mitosis by Anticentromere Antibodies  1527 Figure 9.  Giant mitotic HeLa cell observed in culture 5 d after 
scrape loading with ACA-IgG. (A) DAPI staining of DNA. (B) In- 
direct immunofluorescence staining for tubulin.  This cell has at 
least eight spindle poles. Bar, (A) 1 /~m. 
metaphase plates.  The  remaining  two-thirds  of the  meta- 
phase-arrested cells (14 cells) were unable to achieve meta- 
phase twice.  In these cells chromosomes were distributed 
randomly, from the middle of the spindle to the poles. Thus, 
any inhibitory effect of the antibody on reattachment to the 
spindle is not absolute. 
Terminal Phases of the Affected Mitosis 
It  is  an  unusual  feature  of these  experiments  that  both 
pseudo-prometaphase-arrested and metaphase-arrested cells 
eventually attempt cytokinesis. 
The onset  of anaphase  is  difficult to  detect in  pseudo- 
prometaphase-arrested  cells,  since  the  chromosomes  are 
concentrated in a  single large cluster.  In general, pseudo- 
prometaphase-arrested cells delayed in  mitosis  for longer 
periods exhibit an altered spindle phenotype that becomes 
highly variable (Fig. 7).  In some cells only a disorganized 
patch of microtubules is observed. Although resolution of in- 
dividual chromosomes within the cluster is difficult, adja- 
cent  sister  chromatids  appear  to  have  disjoined  in  a 
significant percentage of cells where they can be resolved. 
We interpret such observations to indicate that these cells 
eventually enter anaphase.  The sister chromatids show no 
sign of poleward movement in these cells. 
Metaphase-arrested cells also eventually enter anaphase. 
In those that enter anaphase while their metaphase plates are 
still somewhat intact,  chromosomes at the plate appear to 
disjoin normally and undergo anaphase A movement towards 
the spindle poles (Fig. 4, C and D). The stray chromosomes 
scattered throughout the cytoplasm also disjoin, but do not 
appear to move (Fig.  5,  G and H). 
A cleavage furrow forms and division is attempted in the 
majority of cells, regardless of whether or not a metaphase 
configuration had been achieved. These attempts at cytoki- 
nesis are often unsuccessful. The progeny of such cleavages 
are typically micronucleated (Fig. 4, E and F), and are con- 
nected by a midbody that contains trapped DNA (Fig. 8, A, 
C, E, and G). Cytokinesis is often reversed in these cells, 
presumably because the process is incapable of proceeding 
to completion when DNA is trapped in the cleavage furrow. 
The detailed aspects of cytokinesis and the midbody struc- 
tures  produced during  attempted cleavage of pseudo-pro- 
metaphase cells are often grossly abnormal. This may be ex- 
plained  by the  abnormal  condition of the  spindle,  whose 
morphology is widely believed to dictate the location of the 
cleavage furrow (33). We often note the initiation and regres- 
sion of several cleavage furrows in different orientations dur- 
ing in vivo observation of such cells attempting cytokinesis. 
The ultimate attempt of these cells to divide often results in 
production of disorganized intracellular bridges with abnor- 
mal midbody structures (Fig. 8). We have observed daughter 
cells with two midbodies side by side and cells that have seg- 
regated portions of their cytoplasm as anucleate karyoplasts. 
Injected Cells Continue to Cycle but Fail to Divide 
Even though these cells are unable to divide normally, many 
of  them continue to grow and traverse the cell cycle. This was 
most evident in  scrape loading experiments,  where many 
large micronucleated cells were observed in populations of 
cells 48 h after loading with ACA-IgG (data not shown). That 
these cells continued to cycle was evidenced by the observa- 
tion of large cells in mitosis,  with multipolar spindles and 
extra sets of chromosomes. When cultures were examined 
5 d after loading, these large cells appeared to have persisted 
and grown even larger,  still  continuing their unsuccessful 
rounds of mitosis (Fig. 9). Such cells were not observed after 
scrape loading with control antibodies. 
Attempts to Identify the Target Antigens 
21 different autoimmune sera were tested for their ability to 
disrupt  mitosis.  While  whole  serum  was  used  for initial 
scrape-loading experiments,  all  microinjections were per- 
formed with IgG purified by chromatography on protein A 
sepharose.  Most (11/15) sera with ACA disrupted mitosis. 
IgG from 5/7 ACA-positive sera disrupted mitosis by micro- 
injection, and 9/15 disrupted mitosis by scrape loading. The 
The Journal of Cell Biology,  Volume 111, 1990  1528 Figure 10. Different ACA(+) sera and ACA-IgG used for microinjection recognize different combinations of the CENP antigens in immuno- 
blots of HeLa chromosomal proteins. Lanes 1-4 show immunoblots with four ACA(+) sera that disrupted mitosis by scrape loading. The 
sera are: lane 1, J-1311; lane 2, A-1219 (lower level of anti-CENP-A); lane 3, KG; lane 4, SN (lower level of anti-CENP-C).  Lanes 5-11 
show immunoblots with ACA-IgG purified from seven sera used in microinjection experiments. ACA-IgG shown in lanes 5-9 disrupted 
mitosis after microinjection, while those in lanes 10 and 11 did not. The sera from which these IgG were isolated are: lane 5, GS (low 
anti-CENP-A and anti-CENP-C);  lane 6, AP (low anti-CENP-C);  lane  7, F-2248;  lane 8, J-3051;  lane 9, H-345 (low anti-CENP-A and 
anti-CENP-C); lane 10, G-2016 (low levels of all antibodies); lane 11, G-1942  (low levels of all three antibodies).  Lanes LL and H show 
immunoblots of nuclei isolated from LLC-PK and HeLa, respectively, with serum AP. (This was a different gel from that shown in lanes 
1-11, and the position of the molecular weight markers is indicated at the right.) All sera and IgG were diluted  1:1,000. The positions of 
CENPs A-D are indicated at the left. Note that only serum AP consistently recognized CENP-D. 
higher  percentage  in  microinjection  experiments  presum- 
ably reflects the introduction  of larger amounts of antibody 
into the cells by this method.  In controls,  four sera contain- 
ing antitopoisomerase I, one with antitopoisomerase II, one 
with non-ACA autoantibodies,  and three normal sera, had no 
effect by either scrape loading or microinjection (as purified 
IgG). The fact that only ACA-positive sera caused the mitotic 
disruption suggests strongly that antibodies to at least one of 
the CENP  antigens  are responsible  for the effect (although 
we cannot rule out the possibility that antibodies recognizing 
a  hitherto  undetected  centromere  antigen  are responsible). 
Although  we have shown previously that >190%  of ACA- 
positive sera recognize three chromosomal antigens, CENPs 
A, B, and C; by screening the bank of 185 ACA-positive sera 
available to us,  we were able to select 8  sera with reduced 
levels of anti-CENP-C and/or anti-CENP-A. All sera that in- 
hibited mitosis had high  levels of anti-CENP-B  antibodies, 
but variable levels of anti-CENP-C  or A by immunoblotting 
analysis  (Fig.  10).  In some instances,  anti-CENP-C  and/or 
anti-CENP-A were virtually undetectable,  particularly after 
purification of the IgG on protein A columns. This is consis- 
tent with  earlier observations that anti-CENP-C  antibodies 
are predominately of the IgM subclass (24).  Those sera that 
did  not  disrupt  mitosis  appeared  to  have  relatively  lower 
titers  of all of the antibodies,  including  anti-CENP-B. 
The results of screening the panel of autoimmune sera sug- 
gested  strongly that CENP-B may be the target antigen  for 
mitotic disruption.  However, three rabbit polyclonal and two 
murine mAbs that were raised against two different CENP-B 
fusion proteins  had  no  effect on mitosis  when  injected  into 
HeLa cells, even though these antibodies were shown by in- 
direct  immunofluorescence  to bind  to centromeres  in vivo 
(data not shown).  These results do not rule out CENP-B as 
the target antigen, however. Rabbit antibodies raised against 
CENP-B fusion proteins recognize only CENP-B, both when 
used  as  crude  serum  and  after  affinity  purification  from 
nitrocellulose strips of chromosomal CENP-B. However, au- 
toantibodies  affinity purified the same way cross-react with 
CENP-A and/or CENP-C.  This suggests that the experimen- 
tal  antibodies  and  autoantibodies  recognize  different  epi- 
topes on CENP-B (9, 10). The inhibitory autoantibodies may 
recognize, for example, a post-translational modification pres- 
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PHENOTYPES OF CELLS INJECTED WITII ACA-IgG 
Figure 11. Diagram showing the mitotic phenotypes of cells after 
nuclear injection with ACA-IgG. The positions of the two execution 
points are indicated. Cytoplasmic injections yield identical pheno- 
types for cells injected '~8 h earlier in the cell cycle. 
ent on chromosomal CENP-B that is absent from fusion pro- 
teins, and is therefore not recognized by the experimental an- 
tibodies. 
The fact that 4 of the 11 ACA-positive sera failed to cause 
a mitotic block may simply reflect the presence of a slightly 
lowered titer of certain critical antibodies. Purified ACA-IgG 
were typically injected at a concentration of 5 mg/ml. With 
an estimated injection volume of 0.1  pl,  this is "~2  ×  106 
IgGs injected per cell. Since we have injected total IgG, only 
3.8%  of the  injected  antibodies  will  be  directed  against 
CENP-B (for serum AP;  N.  E  Rothfield and W.  C.  Earn- 
shaw, unpublished results of quantitative ELISA). We have 
quantitated CENP-B and found it to be present at 30,000- 
50,000 copies per cell (R. L. Bernat and W.  C.  Earnshaw, 
unpublished results). Thus, the antibody against CENP-B is 
present  in  nearly  stoichiometric  amounts  (~76,000  anti- 
CENP-B IgG molecules). Consistent with this, we noted that a 
three-fold dilution of our strongest IgG was typically sufficient 
to abolish the mitotic inhibition. The levels of antibodies to 
CENP-A and CENP-C have not yet been determined, but ex- 
amination of immunoblots suggests that the titers of  these an- 
tibodies are lower than those of anti-CENP-B (9). 
One way to identify the target antigen directly would be 
to affinity purify sufficient amounts of autoantibody from 
each CENP antigen using immunoblots of the chromosomal 
proteins as substrate.  We have attempted this experiment, 
but such affinity-purified antibodies have been inactive in mi- 
totic disruption. This is not surprising, since the CENP anti- 
gens are present in HeLa cells in extremely small amounts, 
and the methods required for affinity purification of these an- 
tibodies  are  extremely harsh  (7,  20).  The  failure  of the 
affinity-purifiedantibodies to disrupt mitosis is probably due 
to a failure to obtain sufficient amounts of active antibody 
(which  requires  IgG  concentrations  in  the  5-10  mg/ml 
range). 
Discussion 
ACA-IgG Disrupt Both the Timing and the Pathway of 
Mitotic Events When Injected into Cultured Cells 
Surprisingly, this mitotic disruption requires interaction of 
the antibody with centromeres during interphase. ACA-IgG 
interfere with at least two interphase processes with different 
"execution points" one '~3 h before mitosis and the other just 
before prophase (Fig.  11). (By analogy to cell cycle mutant 
analysis, we use "execution point" to refer to that time in the 
cycle after which an essential function performed by the tar- 
get  antigen  is  no  longer  sensitive to  antibody disruption 
[32].) When ACA-IgG  were injected into the nucleus/>3 h 
before mitosis, cells were subsequently arrested in pseudo- 
prometaphase with the spindle and the condensed chromo- 
somes lying side by side in the cytoplasm. Antibodies in- 
jected <3 h before mitosis no longer inhibit prometaphase 
function of the centromere, apparently because the required 
interphase events sensitive to antibody inhibition have al- 
ready been completed. Instead,  such injections cause cells 
to arrest in metaphase. Antibodies introduced into cells after 
the onset of prophase do not disrupt the ongoing mitosis, 
even if the injected cells are held in prometaphase for several 
hours in the presence of nocodazole. This, therefore, defines 
a second execution point for antibody inhibition, just before 
the initiation of prophase (Fig.  11). 
The relationship between the two execution points is not 
known. The two phenotypes could represent differences in 
sensitivity of a single epitope at different times in the cell cy- 
cle. Alternatively, the two execution points may reflect inter- 
action of the antibodies with different epitopes affecting dis- 
tinct aspects of centromere function. 
Antibodies injected either into the nucleus or the cytoplasm 
produce identical phenotypes, although cytoplasmic injec- 
tions must be performed at earlier times in the cell cycle to 
give a comparable effect (see Fig. 2). The block in prometa- 
phase becomes progressively stronger at earlier times of cy- 
toplasmic injection, presumably reflecting the rate of anti- 
body transport into the nucleus.  Immunoglobulins are too 
large to pass the nuclear pore passively (3,  12, 43), and yet 
antibodies directed against nuclear antigens have been ob- 
served to accumulate in the nucleus, presumably being trans- 
ported there by newly translated antigen (2, 3, 22, 44, 45). 
We have shown in this study that anticentromere antibodies 
introduced into the cytoplasm enter the nucleus during inter- 
phase with kinetics that could explain the observed delay. 
Although we have thus far been unable to identify the tar- 
get antigens responsible for the disruption of mitosis, a vari- 
ety of circumstantial evidence based on our analysis of the 
effects of 15 different ACA-positive patient sera suggests that 
at least some of the inhibitory effects may be due to autoanti- 
bodies recognizing CENP-B. 
The Pseudo-prometaphase  Arrest May Result from a 
Disruption of Centromere Assembly 
The execution point for pseudo-prometaphase arrest appears 
to correspond roughly to the S/G2 transition (Fig.  11). The 
end of the S phase is the time of replication of a-satellite 
DNA, one of the major structural components of the human 
centromere (20). It has recently been shown that CENP-B 
binds to a  17-bp sequence found in many a-satellite DNA 
repeats (23). It is likely that this binding occurs in vivo either 
coordinate with, or soon after a-satellite DNA replication. 
The position of the execution point for prometaphase arrest 
at roughly the same time in the cell cycle thus suggests that 
the antibody may cause the improper assembly of CENP-B 
onto a-satellite DNA (or prevent other centromeric proteins 
from assembling correctly onto the CENP-B:a-satellite DNA 
complex). Staining with anti-CENP-B reveals that this pro- 
tein is present at the centromeres of the blocked cells (data 
not shown), but it is not possible with currently available an- 
tibodies  to  tell  whether the  localization of CENP-A  and 
CENP-C is normal in these cells. 
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presence of microtubules that appeared to be associated with 
the  centromeres  in  pseudo-prometaphase-arrested  cells. 
This suggests that the centromere defect induced by ACA- 
IgG produces a  structure capable of binding microtubules 
but incapable of moving along them. This is consistent with 
our immunoelectron microscopy experiments in which we 
have  been  unable  to  detect  these  antigens  in  the  outer 
kinetochore plate, where the majority of the microtubules 
are known to bind (6,  34).  The inhibition of chromosome 
movement may be a consequence of the failure to assemble 
a  functional kinetochore structure.  Alternatively, the anti- 
body may directly inactivate some component of the mechano- 
chemical motor responsible for chromosome movement. Fu- 
ture EM studies should reveal whether the antibodies cause 
any observable defects in kinetochore morphology. 
The inhibition of prometaphase movements by  injected 
ACA-IgG has interesting implications for the structure/func- 
tion of the centromere, since our recent immunoelectron mi- 
croscopy results indicate that the antigens targeted by these 
antibodies are found in the chromatin surrounding the kinet- 
ochore (6). Thus, this chromatin might be more interesting 
than had previously been thought. It is worth noting that a 
recent study has shown that early prometaphase movements 
in the newt lung cell involve the lateral interaction of micro- 
tubules with the corona region of the kinetochore (36). The 
relationship  between  the  corona material  and  the  CENP 
antigen-rich chromatin surrounding the kinetochore plate is 
unknown. 
The presence of a bipolar spindle in pseudo-prometaphase 
cells was unexpected, and suggests that the formation of a 
bipolar spindle may not be strictly dependent on the presence 
of bioriented chromosomes at the spindle equator. Appar- 
ently two adjacent asters will eventually generate a bipolar 
spindle between them even in the absence of the normal cap- 
ping structures such as kinetochores. 
Injection of  ACA-IgG into the Nucleus 
during G2 Disrupts the Timing of the 
Metaphase-Anaphase Transition 
This defines a second execution point for antibody inhibition 
just before the beginning of prophase. The kinetochore be- 
gins to undergo a series of morphological changes at the on- 
set of prophase, culminating in the appearance of a trilami- 
nar plaque structure in prometaphase (37). The metaphase 
arrest may require antibody binding to the centromere before 
the onset of these morphological changes. 
The reason for the antibody-induced metaphase arrest is 
unknown.  Normal  initiation  of the  metaphase-anaphase 
transition  requires  passage  of  the  metaphase  cell  cycle 
checkpoint, a process that senses completion of the bipolar 
attachment  of the  chromosomes  to  the  spindle  (35,  53). 
ACA-IgG  injection  may  disrupt  kinetochore  structure, 
resulting in defective attachment of the chromosomes to the 
spindle so that even though the chromosomes achieve a bipo- 
lar orientation that appears normal, the resulting structure 
is aberrant. Alternatively, ACA-IgG may disrupt the signal- 
ing network directly by binding to a centromere component 
involved in the pathway. It is unlikely that the metaphase de- 
lay arises from an inability of the chromosomes to disjoin, 
since separation of sister chromatids can occur in these cells, 
albeit in an altered temporal and spatial context. 
Chromosomes begin to detach from the spindle and be- 
come randomly distributed throughout the cell as cells re- 
main blocked in metaphase. Our present data do not allow 
us to determine whether this chromosome detachment is a 
cause or a consequence of the metaphase arrest. A  similar 
phenotype has been observed in a hamster cell cycle mutant, 
which undergoes a similar metaphase arrest, followed by the 
eventual  dispersion  of chromosomes  throughout  the  cell 
(49,  50). 
Detachment of chromosomes could be a consequence of 
kinetochore breakage  similar  to  that  induced by  caffeine 
treatment of hydroxyurea-arrested cells (39). In such cells, 
the kinetochores apparently detach from the chromosomes 
and participate in the formation of a bipolar spindle (4). Any 
kinetochore detachment that occurs as a consequence of an- 
tibody injection must be highly localized, however, since we 
have shown that the detached chromosomes stain normally 
with anticentromere antibodies. 
Alternatively, the normal oscillations of chromosomes at 
the metaphase plate might result in transient detachment of 
the chromosome-spindle connections, which may be unable 
to reform normally in the presence of structural abnormali- 
ties induced by the injected antibody. This seems unlikely 
since cells arrested in metaphase by injection of ACA-IgG 
are in many instances able to reform metaphase plates after 
a transient exposure to nocodazole. 
Although Cells Injected with ACA-IgG  Are 
Arrested in Mitosis  for Up to Eight Hours, Most 
Eventually Attempt Cytokinesis 
These attempts are often unsuccessful, presumably because 
the process is incapable of proceeding to completion when 
DNA is trapped in the cleavage furrow. DNA entrapment ap- 
parently results from the failure of some of  the chromosomes 
to  move  during  anaphase.  This  is  most  extreme  in  the 
pseudo-prometaphase-arrested cells, where we are unable to 
detect chromosome movement at any time during mitosis 
(Fig.  8).  The effect is  less  pronounced in  cells  that  had 
formed metaphase plates.  Those chromosomes still at the 
spindle equator at the onset of anaphase successfully disjoin 
and move to the spindle poles (Fig. 4).  Chromosomes that 
had detached from the plate apparently do not move and be- 
come trapped in the cleavage furrow. 
The ultimate  result of this  abortive cytokinesis bears a 
striking resemblance to the cut phenotype observed in topo- 
isomerase II mutants of S. cerevisiae  and S. pombe (18, 46) 
as well as in the S. pombe cut mutants (17). The ACA-IgG- 
induced cut phenotype is distinct from that induced by topo- 
isomerase II mutants, however, since we often observe dis- 
junction of sister chromatids. It is possible that one or more 
of the S. pombe cut mutants  affects a  centromere protein 
related to one or more of the CENP antigens. 
That  pseudo-prometaphase-arrested cells eventually at- 
tempt cytokinesis is surprising, particularly in HeLa cells, 
which are stably arrested in prometaphase by colcemid treat- 
ment, and do not progress through mitosis even after 12- 
20 h in the drug. Since the only obvious difference between 
the injected cells and cells blocked with colcemid is the pres- 
ence of microtubules, this suggests that the cellular mecha- 
nism responsible for initiation of cytokinesis requires micro- 
tubules.  This  is  consistent with the earlier demonstration 
that cells such as sea urchin eggs that undergo successive cell 
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of cleavage furrows or other signs of cytokinesis (42). 
While these experiments were in progress, Simerly et al. 
(40) conducted similar experiments on the effect of anticen- 
tromere antibodies microinjected into mouse oocytes. Like 
our study, they found that injection into interphase cells in- 
terfered with chromosome congression at the subsequent mi- 
tosis.  However,  unlike  our results,  antibody  injected  into 
nocodazole-arrested cells also interfered with  congression 
after drug removal. They concluded that the effect was not 
due to a  disruption of kinetochore maturation but,  rather, 
was on the congression mechanism itself. The basis for the 
difference in results in the two systems is not known at pres- 
ent, although one obvious possibility is differences between 
man and mouse in the organization of the centromeric repeti- 
tive DNAs that bind CENP-B. 
Conclusions 
Our experiments reveal the existence of antibody-sensitive 
events during interphase that are essential for the ability of 
the  centromere to  undergo  microtubule-based movements 
during mitosis.  These events, which may include essential 
stages in the assembly of the centromere, occur at a time of 
the cell cycle when centromere structure cannot be resolved 
directly. The availability of cDNA clones and specific anti- 
bodies for the CENP antigens should permit their analysis 
in the future. 
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